A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy on joint damage and safety in RA patients
treated with DMARDs in a double blind, placebo controlled study.